These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31894424)
1. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy. Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J; Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424 [TBL] [Abstract][Full Text] [Related]
2. An overview protocol of biomarkers for breast cancer detection. Sheng Z; Wang J; Li M; Luo X; Cai R; Zhang M; Medicine (Baltimore); 2019 Jun; 98(24):e16024. PubMed ID: 31192953 [TBL] [Abstract][Full Text] [Related]
3. Relationship between diagnostic accuracy of microRNAs for NSCLC and number of combined microRNAs: an overview with meta-analysis. Li M; Gao Y; Shi J; Zhang Y; Zhang M; Tian J Expert Rev Mol Diagn; 2021 Sep; 21(9):983-993. PubMed ID: 34192984 [No Abstract] [Full Text] [Related]
4. Quantitative assessment of the association between APC promoter methylation and breast cancer. He K; Zhang L; Long X Oncotarget; 2016 Jun; 7(25):37920-37930. PubMed ID: 27191268 [TBL] [Abstract][Full Text] [Related]
5. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis. Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy. Zan X; Wang Y; Shi J; Zhao L; Zhao Y; Liu R; Zhou Y; Wan Y; Medicine (Baltimore); 2019 Jun; 98(24):e16028. PubMed ID: 31192957 [TBL] [Abstract][Full Text] [Related]
7. The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy. Wang J; Liang W; Wang X; Min G; Chen W; Wang H; Yao N; Wang J; Medicine (Baltimore); 2019 Jun; 98(24):e16034. PubMed ID: 31192959 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons. Hua J; Liu J; Hua M; Cai R; Li M; Wang J; Wang J; Medicine (Baltimore); 2019 May; 98(18):e15508. PubMed ID: 31045839 [TBL] [Abstract][Full Text] [Related]
9. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse. Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of ESR1 mutation detection by cell-free DNA in breast cancer: a systematic review and meta-analysis of diagnostic test accuracy. Raei M; Heydari K; Tabarestani M; Razavi A; Mirshafiei F; Esmaeily F; Taheri M; Hoseini A; Nazari H; Shamshirian D; Alizadeh-Navaei R BMC Cancer; 2024 Jul; 24(1):908. PubMed ID: 39069608 [TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers for detecting prostate cancer: Protocol for an umbrella review with integrated network meta-analysis. Jia J; Sun Y; Ren J; Li M; Wang J; Li H; Medicine (Baltimore); 2019 Jul; 98(30):e16517. PubMed ID: 31348264 [TBL] [Abstract][Full Text] [Related]
13. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis. Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533 [TBL] [Abstract][Full Text] [Related]
14. APC gene promoter aberrant methylation in serum as a biomarker for breast cancer diagnosis: A meta-analysis. Qian X; Ruan L Thorac Cancer; 2018 Feb; 9(2):284-290. PubMed ID: 29297603 [TBL] [Abstract][Full Text] [Related]
15. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis. Liu F; Lu X; Zhou X; Huang H Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707 [TBL] [Abstract][Full Text] [Related]
16. CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis. Tang S; Wei L; Sun Y; Zhou F; Zhu S; Yang R; Huang Y; Zhang H; Xu H; Yang J PLoS One; 2016; 11(9):e0163030. PubMed ID: 27636552 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis. Li B; Pu K; Ge L; Wu X Gene; 2019 Sep; 714():143993. PubMed ID: 31330238 [TBL] [Abstract][Full Text] [Related]
18. Comparison of value of biomarkers in diagnosing lung cancer: An overview of systematic reviews protocol. Wu F; Wang H; Tao H; Huang H; Zhang L; Wu D; Wan Y; Medicine (Baltimore); 2019 May; 98(19):e15525. PubMed ID: 31083197 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA Dysregulation in Early Breast Cancer Diagnosis: A Systematic Review and Meta-Analysis. Garrido-Palacios A; Rojas Carvajal AM; Núñez-Negrillo AM; Cortés-Martín J; Sánchez-García JC; Aguilar-Cordero MJ Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175974 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review. Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]